verapamil has been researched along with Cardiomyopathies in 92 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a case in which low-dose verapamil resulted in marked worsening of congestive heart failure, as a result of a profound negative inotropic effect." | 7.68 | Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis. ( Falk, RH; Pollak, A, 1993) |
| " Nifedipine and diltiazem are effective in the relief of angina, and verapamil is used in the treatment of supraventricular tachyarrhythmias." | 4.77 | Calcium channel blocking agents: physiologic basis of nursing intervention. ( Touloukian, JE, 1985) |
| " We report a case in which low-dose verapamil resulted in marked worsening of congestive heart failure, as a result of a profound negative inotropic effect." | 3.68 | Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis. ( Falk, RH; Pollak, A, 1993) |
| " Previous studies have shown that therapy for several weeks with the calcium channel blocking drug verapamil or the alpha-1 adrenoceptor blocking drug prazosin can prevent myocardial necrosis due to microvascular spasm." | 3.67 | Prevention of hereditary cardiomyopathy in the Syrian hamster with chronic verapamil therapy. ( Cho, SH; Factor, SM; Malhotra, A; Scheuer, J; Sonnenblick, EH, 1988) |
| "In the following study, patients with acute myeloid leukemia (AML) treated with double induction and consolidation chemotherapy (AML COOP study 1986, [3]) were randomized in a group with and without accompanying low-dose oral verapamil treatment." | 2.67 | Effects of verapamil on anthracycline-induced cardiomyopathy: preliminary results of a prospective multicenter trial. ( Appelt, M; Büchner, T; Eichelbaum, M; Grille, W; Hiddemann, W; Hossfeld, DK; Koslowski, B; Kraft, J; Kuse, R; Quabeck, K, 1990) |
| "In 6 patients, arrhythmias were controlled after extracorporeal membrane oxygenation (ECMO) support; 5 of these patients survived." | 1.72 | Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises. ( Azamian, M; Beach, CM; Ceresnak, SR; Delauz, CM; Ehsan, SA; Glinton, KE; Houck, KM; Howard, TS; Janson, CM; Jardine, K; Kannankeril, PJ; Kava, M; Kim, JJ; Lalani, SR; Lay, EJ; Li, N; Liberman, L; Macicek, SL; Milewicz, DM; Miyake, CY; Pham, TD; Robertson, T; Soler-Alfonso, C; Stephens, SB; Tosur, M; Valdes, SO; Webster, G; Xu, W; Zhang, L, 2022) |
| "Verapamil-sensitive fascicular ventricular tachycardia is a rare arrhythmogenic condition characterized by a right bundle-branch block pattern and left-axis deviation with a relatively narrow QRS complex." | 1.40 | Verapamil-sensitive fascicular ventricular tachycardia in a patient with isolated left ventricular noncompaction. ( Chen, MY; Ying, ZQ, 2014) |
| "Verapamil treatment eliminated evidence of vasospasm and ameliorated histological and functional evidence of cardiomyopathic progression." | 1.32 | Secondary coronary artery vasospasm promotes cardiomyopathy progression. ( Collins, KA; Earley, JU; Hack, AA; Korcarz, CE; Lang, RM; Lapidos, KA; Lyons, MR; McNally, EM; Wheeler, MT; Zarnegar, S, 2004) |
| "Ryanodine and verapamil were studied for comparison." | 1.31 | Effect of volatile anesthetics on the force-frequency relation in human ventricular myocardium: the role of the sarcoplasmic reticulum calcium-release channel. ( Braun, V; Greiser, M; Hanrath, P; Karlein, C; Schoendube, F; Schotten, U, 2001) |
| "Trimetazidine was administered to cardiomyopathic hamsters from the early stage of active disease (30 days) to the congestive stages (220-350 days)." | 1.30 | Effect of trimetazidine and verapamil on the cardiomyopathic hamster myosin phenotype. ( D'hahan, N; Janmot, C; Morel, JE; Taouil, K, 1998) |
| "The treatment with verapamil led to a normal rhythm and function of the heart." | 1.30 | [Verapamil sensitive ventricular tachycardia with myocardial failure in a 2-year-old child]. ( Gossen, N; Liersch, R; Ulbricht, LJ; Winter, K, 1999) |
| "Mibefradil doses were in the range of 0." | 1.30 | Cardioprotective efficacy of verapamil and mibefradil in young UM-X7.1 cardiomyopathic hamsters. ( Dumont, L; Jasmin, G; Paquette, F, 1999) |
| "Verapamil was an effective inhibitor of peroxidative damage to myocardial lipids following a high dose of doxorubicin (15 mg/kg, injected intraperitoneally)." | 1.28 | Effects of verapamil on the acute toxicity of doxorubicin in vivo. ( Anderson, J; Baker, PB; Desai, P; Dwivedi, C; Engineer, FN; Sharma, HM; Sridhar, R, 1992) |
| "The tachycardias were nonsustained in 24 patients, sustained (greater than 30 sec) in six patients, and provocable by exercise in 14 of 23 patients undergoing a standard Bruce protocol." | 1.27 | Right ventricular tachycardia: clinical and electrophysiologic characteristics. ( Buxton, AE; Cassidy, D; Josephson, ME; Marchlinski, FE; Simson, MB; Waxman, HL, 1983) |
| "Bepridil (10 mg/kg) was injected twice daily for 15 and 30 days." | 1.27 | Comparison of verapamil and bepridil in the therapy of familiar cardiomyopathy of the Syrian hamster. ( Hofmann, U; Kunkel, B; Mutschler, M, 1987) |
| "Verapamil-treated myopathic hamsters had evidence of markedly improved mitochondrial function when compared with untreated animals." | 1.27 | Evaluation of the hereditary Syrian hamster cardiomyopathy by 31P nuclear magnetic resonance spectroscopy: improvement after acute verapamil therapy. ( Higgins, CB; James, TL; Jasmin, G; Markiewicz, W; Parmley, WW; Sievers, R; Wikman-Coffelt, J; Wu, SS, 1986) |
| "In the patients with a left bundle branch block morphology of VT (7 cases), four showed findings compatible with an arrhythmogenic right ventricular dysplasia or a right ventricular cardiomyopathy." | 1.27 | Morphological findings in apparently idiopathic ventricular tachycardia. An echocardiographic haemodynamic and histologic study. ( Alberti, E; Camerini, F; Morgera, T; Salvi, A; Silvestri, F, 1985) |
| "The effect of inhibiting isoprenaline-induced intracellular calcium accumulation on the degree of damage produced in the rat myocardium by this amine has been investigated by simultaneously dosing rats with the calcium antagonistic drug D600." | 1.26 | The effect of a calcium antagonist (D600) on isoprenaline-induced myocardial necrosis in the rat. ( Powell, T; Rowles, PM; Steen, E; Woolf, N, 1979) |
| "Fifty pregnant women admitted consecutively on account of threatened abortion or premature labour and treated with Ritodrine and Verapamil intravenously in the usual dosage were investigated with respect to creatine kinase activity and, in the event of a raised level, its isoenzyme creatine kinase--MB." | 1.26 | [Does myocardial damage arise as a result of administration of tocolytic drugs? (author's transl)]. ( Dienstl, F; Lechner, W, 1979) |
| "Fifty pregnant women admitted consecutively on account of threatened abortion or premature labour and treated with Ritodrine and Verapamil intravenously in the usual dosage were investigated with respect to creatine kinase activity and, in the event of a raised level, its isoenzyme creatine kinase--MB." | 1.26 | [Does myocardial damage arise as a result of administration of tocolytic drugs? (author's transl)]. ( Dienstl, F; Lechner, W, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 58 (63.04) | 18.7374 |
| 1990's | 22 (23.91) | 18.2507 |
| 2000's | 9 (9.78) | 29.6817 |
| 2010's | 2 (2.17) | 24.3611 |
| 2020's | 1 (1.09) | 2.80 |
| Authors | Studies |
|---|---|
| Miyake, CY | 1 |
| Lay, EJ | 1 |
| Beach, CM | 1 |
| Ceresnak, SR | 1 |
| Delauz, CM | 1 |
| Howard, TS | 1 |
| Janson, CM | 1 |
| Jardine, K | 1 |
| Kannankeril, PJ | 1 |
| Kava, M | 1 |
| Kim, JJ | 1 |
| Liberman, L | 1 |
| Macicek, SL | 1 |
| Pham, TD | 1 |
| Robertson, T | 1 |
| Valdes, SO | 1 |
| Webster, G | 1 |
| Stephens, SB | 1 |
| Milewicz, DM | 1 |
| Azamian, M | 1 |
| Ehsan, SA | 1 |
| Houck, KM | 1 |
| Soler-Alfonso, C | 1 |
| Glinton, KE | 1 |
| Tosur, M | 1 |
| Li, N | 1 |
| Xu, W | 1 |
| Lalani, SR | 1 |
| Zhang, L | 1 |
| Ying, ZQ | 1 |
| Chen, MY | 1 |
| Sugishita, K | 1 |
| Asakawa, M | 1 |
| Usui, S | 1 |
| Takahashi, T | 1 |
| Fajardo, G | 1 |
| Zhao, M | 1 |
| Berry, G | 1 |
| Wong, LJ | 1 |
| Mochly-Rosen, D | 1 |
| Bernstein, D | 1 |
| Oudit, GY | 1 |
| Sun, H | 1 |
| Trivieri, MG | 1 |
| Koch, SE | 1 |
| Dawood, F | 1 |
| Ackerley, C | 1 |
| Yazdanpanah, M | 1 |
| Wilson, GJ | 1 |
| Schwartz, A | 1 |
| Liu, PP | 1 |
| Backx, PH | 1 |
| Wheeler, MT | 1 |
| Korcarz, CE | 1 |
| Collins, KA | 1 |
| Lapidos, KA | 1 |
| Hack, AA | 1 |
| Lyons, MR | 1 |
| Zarnegar, S | 1 |
| Earley, JU | 1 |
| Lang, RM | 1 |
| McNally, EM | 1 |
| Couture, L | 1 |
| Nash, JA | 1 |
| Turgeon, J | 1 |
| Abu-Fanne, R | 1 |
| Rott, D | 1 |
| Klein, M | 1 |
| Leitersdorf, E | 1 |
| Pollak, A | 2 |
| Pflederer, W | 1 |
| Buxton, AE | 1 |
| Waxman, HL | 1 |
| Marchlinski, FE | 1 |
| Simson, MB | 1 |
| Cassidy, D | 1 |
| Josephson, ME | 1 |
| Kuo, TH | 1 |
| Ho, KL | 1 |
| Wiener, J | 1 |
| Halawa, B | 1 |
| Mazurek, W | 1 |
| Rouleau, JL | 1 |
| Chuck, LH | 1 |
| Hollosi, G | 1 |
| Kidd, P | 1 |
| Sievers, RE | 1 |
| Wikman-Coffelt, J | 2 |
| Parmley, WW | 2 |
| Müllerleile, U | 2 |
| Garbrecht, M | 2 |
| Hanrath, P | 2 |
| Langenstein, BA | 1 |
| Bieber, K | 1 |
| Bleifeld, W | 1 |
| Hossfeld, DK | 2 |
| Maurer, E | 1 |
| Nicoletti, R | 1 |
| Brandt, D | 1 |
| Klein, W | 1 |
| Hombach, V | 1 |
| Braun, V | 2 |
| Höpp, HW | 1 |
| Behrenbeck, DW | 1 |
| Tauchert, M | 1 |
| Hilger, HH | 1 |
| Polverino, W | 1 |
| Basso, A | 1 |
| Muto, P | 1 |
| Genovese, A | 1 |
| Perrone, V | 1 |
| Apice, G | 1 |
| Farace, J | 1 |
| Stix, J | 1 |
| Dressler, F | 1 |
| Saling, E | 1 |
| Check, WA | 1 |
| Decorti, G | 2 |
| Bartoli Klugmann, F | 2 |
| Klugmann, S | 2 |
| Factor, SM | 5 |
| Minase, T | 1 |
| Cho, S | 2 |
| Dominitz, R | 1 |
| Sonnenblick, EH | 5 |
| Pinsky, WW | 1 |
| Lewis, RM | 1 |
| McMillin-Wood, JB | 1 |
| Hara, H | 1 |
| Hartley, CJ | 1 |
| Gillette, PC | 1 |
| Entman, ML | 1 |
| Gori, D | 1 |
| Silvestri, F | 2 |
| Camerini, F | 2 |
| Strigl, R | 1 |
| Pfeiffer, U | 1 |
| Erhardt, W | 1 |
| Blümel, G | 1 |
| Slater, JP | 1 |
| Lipsitz, EC | 1 |
| Chen, JM | 1 |
| Levin, HR | 1 |
| Oz, MC | 1 |
| Burkhoff, D | 1 |
| Finkel, MS | 2 |
| Shen, L | 1 |
| Oddis, CV | 2 |
| Romeo, RC | 2 |
| Salama, G | 2 |
| Rossi, F | 1 |
| Filippelli, W | 1 |
| Russo, S | 1 |
| Filippelli, A | 1 |
| Berrino, L | 1 |
| Watanabe, K | 1 |
| Shibata, A | 1 |
| Wakabayashi, H | 1 |
| Shimada, K | 1 |
| Sasaki, K | 1 |
| Nagatomo, T | 1 |
| Falk, RH | 1 |
| Kobayashi, A | 3 |
| Nishiyama, T | 1 |
| Ikegaya, T | 1 |
| Kaneko, M | 1 |
| Yamazaki, N | 3 |
| D'hahan, N | 1 |
| Taouil, K | 1 |
| Janmot, C | 1 |
| Morel, JE | 1 |
| Winter, K | 1 |
| Gossen, N | 1 |
| Ulbricht, LJ | 1 |
| Liersch, R | 1 |
| Jelicks, LA | 1 |
| Shirani, J | 1 |
| Wittner, M | 1 |
| Chandra, M | 1 |
| Weiss, LM | 1 |
| Bekirov, I | 1 |
| Braunstein, VL | 1 |
| Chan, J | 1 |
| Huang, H | 1 |
| Tanowitz, HB | 1 |
| Paquette, F | 1 |
| Jasmin, G | 4 |
| Dumont, L | 1 |
| Gordon, EA | 1 |
| Guppy, LJ | 1 |
| Towbin, JA | 1 |
| Bowles, NE | 1 |
| Cohn, RD | 1 |
| Durbeej, M | 1 |
| Moore, SA | 1 |
| Coral-Vazquez, R | 1 |
| Prouty, S | 1 |
| Campbell, KP | 1 |
| Hill, RE | 1 |
| Heard, K | 1 |
| Bogdan, GM | 1 |
| Cairns, CB | 1 |
| Dart, RC | 1 |
| Schotten, U | 1 |
| Greiser, M | 1 |
| Karlein, C | 1 |
| Schoendube, F | 1 |
| Strubelt, O | 1 |
| Siegers, CP | 1 |
| Lossnitzer, K | 2 |
| Konrad, A | 1 |
| Heine, HW | 1 |
| Ziegler, E | 1 |
| Stauch, M | 2 |
| Sekeff, JA | 1 |
| Perez, VP | 1 |
| Freitas, LB | 1 |
| Dohmann, HJ | 1 |
| Hasin, Y | 1 |
| Rod, JL | 1 |
| Friedman, G | 1 |
| Vichi, FL | 1 |
| Nobre, F | 1 |
| Evora, P | 1 |
| Ribeiro, PJ | 1 |
| Papa, MV | 1 |
| Steen, E | 1 |
| Woolf, N | 1 |
| Powell, T | 1 |
| Rowles, PM | 1 |
| Lechner, W | 2 |
| Dienstl, F | 2 |
| Dohmae, N | 1 |
| Sawada, H | 1 |
| Tashima, M | 1 |
| Uchino, H | 1 |
| Matsuyama, E | 1 |
| Konishi, T | 1 |
| Rossner, KL | 1 |
| Sachs, HG | 1 |
| Hopf, R | 2 |
| Keller, M | 1 |
| Kaltenbach, M | 2 |
| Solymoss, B | 1 |
| Sigel, H | 1 |
| Janke, J | 4 |
| Fleckenstein, A | 5 |
| Hein, B | 1 |
| Bajusz, E | 1 |
| Kanke, J | 1 |
| Döring, HJ | 3 |
| Leder, O | 2 |
| Paul, S | 1 |
| York, D | 1 |
| Lee, SL | 1 |
| Ostadalova, I | 1 |
| Kolar, F | 1 |
| Dhalla, NS | 3 |
| Sridhar, R | 1 |
| Dwivedi, C | 1 |
| Anderson, J | 1 |
| Baker, PB | 1 |
| Sharma, HM | 1 |
| Desai, P | 1 |
| Engineer, FN | 1 |
| Sen, LY | 1 |
| O'Neill, M | 1 |
| Marsh, JD | 1 |
| Smith, TW | 1 |
| Yu, Z | 1 |
| McNeill, JH | 1 |
| Fein, FS | 1 |
| Zola, BE | 1 |
| Malhotra, A | 2 |
| Scheuer, J | 2 |
| Howlett, SE | 1 |
| Gordon, T | 1 |
| Kraft, J | 1 |
| Grille, W | 1 |
| Appelt, M | 1 |
| Eichelbaum, M | 1 |
| Koslowski, B | 1 |
| Quabeck, K | 1 |
| Kuse, R | 1 |
| Büchner, T | 1 |
| Hiddemann, W | 1 |
| Capasso, JM | 2 |
| Anversa, P | 1 |
| Bright, JM | 1 |
| Buss, DD | 1 |
| Popovich, LF | 1 |
| Figulla, HR | 1 |
| Vetterlein, F | 1 |
| Glaubitz, M | 1 |
| Kreuzer, H | 1 |
| Afzal, N | 2 |
| Pierce, GN | 2 |
| Elimban, V | 1 |
| Beamish, RE | 1 |
| Villani, A | 1 |
| Primieri, P | 1 |
| De Cosmo, G | 1 |
| Kurata, C | 1 |
| Cho, SH | 1 |
| Tapp, WN | 1 |
| Natelson, BH | 1 |
| Ganguly, PK | 1 |
| Dhalla, KS | 1 |
| Singal, PK | 1 |
| Sievert, H | 1 |
| Kunkel, B | 2 |
| Wirtz, M | 1 |
| Hofmann, U | 1 |
| Mutschler, M | 1 |
| Gwathmey, JK | 1 |
| Copelas, L | 1 |
| MacKinnon, R | 1 |
| Schoen, FJ | 1 |
| Feldman, MD | 1 |
| Grossman, W | 1 |
| Morgan, JP | 1 |
| Lehot, JJ | 1 |
| Leone, BJ | 1 |
| Foëx, P | 1 |
| Yamashita, T | 1 |
| Miura, K | 1 |
| Shirasawa, H | 1 |
| Markiewicz, W | 1 |
| Wu, SS | 1 |
| Higgins, CB | 1 |
| Sievers, R | 1 |
| James, TL | 1 |
| Fein, F | 1 |
| Touloukian, JE | 1 |
| Kasanuki, H | 1 |
| Onishi, S | 1 |
| Hirosawa, K | 1 |
| Simpson, WG | 1 |
| Tseng, MT | 1 |
| Harty, JI | 1 |
| Guazzi, MD | 1 |
| De Cesare, N | 1 |
| Galli, C | 1 |
| Salvioni, A | 1 |
| Tamborini, G | 1 |
| Tosi, E | 1 |
| Cameron, JS | 1 |
| Miller, LS | 1 |
| Kimura, S | 1 |
| Kaiser, CJ | 1 |
| Campbell, DR | 1 |
| Kozlovskis, PL | 1 |
| Gaide, MS | 1 |
| Myerburg, RJ | 1 |
| Bassett, AL | 1 |
| Morgera, T | 1 |
| Salvi, A | 1 |
| Alberti, E | 1 |
| Welty, JD | 1 |
| McBroom, MJ | 1 |
| Zahavi, I | 1 |
| Chagnac, A | 1 |
| Djaldetti, M | 1 |
| Katz, M | 1 |
| Levi, J | 1 |
| Pachinger, O | 1 |
4 reviews available for verapamil and Cardiomyopathies
| Article | Year |
|---|---|
The ATP-binding cassette transporters and their implication in drug disposition: a special look at the heart.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cas | 2006 |
[Cardiomyopathies and their treatment].
Topics: Adult; Aged; Aortic Stenosis, Subvalvular; Cardiomegaly; Cardiomyopathies; Cardiomyopathy, Alcoholic | 1980 |
Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy.
Topics: Animals; Cardiomyopathies; Cardiomyopathy, Hypertrophic; Coronary Vasospasm; Cricetinae; Heart Failu | 1985 |
Calcium channel blocking agents: physiologic basis of nursing intervention.
Topics: Angina Pectoris; Angina Pectoris, Variant; Atrioventricular Node; Calcium; Calcium Channel Blockers; | 1985 |
8 trials available for verapamil and Cardiomyopathies
| Article | Year |
|---|---|
[Possible prevention of adriamycin-induced cardiomyopathy by verapamil. Results of a pilot study].
Topics: Cardiomyopathies; Doxorubicin; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contracti | 1984 |
Effect of calcium antagonists on cardiac performance in patients with dilatative cardiomyopathy evaluated by noninvasive methods.
Topics: Adult; Calcium; Calcium Channel Blockers; Cardiomyopathies; Diltiazem; Drug Therapy, Combination; Ec | 1983 |
Calcium antagonists: long-awaited new therapy for heart disease.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Calcium; Cardiomyopathies; Clinical Trials as T | 1981 |
[Evaluation of verapamil in the treatment of idiopathic cardiac hypertrophy].
Topics: Adult; Aortic Valve Stenosis; Cardiomegaly; Cardiomyopathies; Clinical Trials as Topic; Drug Evaluat | 1977 |
[Use of verapamil in the treatment of ventricular extrasystole in chronic Chagas' heart disease].
Topics: Cardiomyopathies; Chagas Disease; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Drug | 1977 |
Effects of verapamil on anthracycline-induced cardiomyopathy: preliminary results of a prospective multicenter trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cytarabine; Dau | 1990 |
Calcium antagonist treatment in mild forms of cardiomyopathy.
Topics: Adult; Calcium Channel Blockers; Cardiomyopathies; Female; Hemodynamics; Humans; Male; Middle Aged; | 1987 |
[Nifedipine as a vasodilator antihypertensive with a rapid action].
Topics: Adrenal Gland Neoplasms; Antihypertensive Agents; Brain Diseases; Cardiomyopathies; Emergencies; Hem | 1985 |
80 other studies available for verapamil and Cardiomyopathies
| Article | Year |
|---|---|
Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Child; Heart Arrest; Humans; Isoprot | 2022 |
Verapamil-sensitive fascicular ventricular tachycardia in a patient with isolated left ventricular noncompaction.
Topics: Anti-Arrhythmia Agents; Bundle-Branch Block; Cardiomyopathies; Echocardiography, Doppler, Color; Ele | 2014 |
A case of iron overload cardiomyopathy: beneficial effects of iron chelating agent and calcium channel blocker on left ventricular dysfunction.
Topics: Aged, 80 and over; Calcium Channel Blockers; Cardiomyopathies; Deferoxamine; Ferritins; Humans; Iron | 2009 |
β2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Apoptosis; Calcium; Calcium Channel Blockers; Card | 2011 |
L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy.
Topics: Amlodipine; Animals; Biological Transport; Calcium Channel Blockers; Calcium Channels; Cardiomyopath | 2003 |
Secondary coronary artery vasospasm promotes cardiomyopathy progression.
Topics: Animals; Calcium Channel Blockers; Cardiomyopathies; Coronary Vasospasm; Cytoskeletal Proteins; Dise | 2004 |
Recurrent apical ballooning despite treatment with verapamil.
Topics: Aged; Calcium Channel Blockers; Cardiomyopathies; Coronary Angiography; Diagnosis, Differential; Ele | 2007 |
[Therapy of cardiomyopathies].
Topics: Adrenergic beta-Agonists; Anti-Arrhythmia Agents; Anticoagulants; Captopril; Cardiac Glycosides; Car | 1982 |
Right ventricular tachycardia: clinical and electrophysiologic characteristics.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Bundle-Branch Block; C | 1983 |
The role of alkaline protease in the development of cardiac lesions in myopathic hamsters: effect of verapamil treatment.
Topics: Aging; Animals; Cardiomyopathies; Cricetinae; Endopeptidases; Female; Genes, Recessive; Muscles; Myo | 1984 |
Verapamil preserves myocardial contractility in the hereditary cardiomyopathy of the Syrian hamster.
Topics: Actins; Adenosine Triphosphatases; Animals; Cardiomyopathies; Cricetinae; Digoxin; Hydralazine; Meso | 1982 |
[Non-invasive derivation of potential of the bundle of His from the body surface (author's transl)].
Topics: Adult; Aged; Ajmaline; Bundle of His; Cardiomyopathies; Electrocardiography; Evoked Potentials; Fema | 1981 |
[Calcium antagonists: effects on cardiotoxicity caused by adriamycin. Preliminary trials].
Topics: Adolescent; Adult; Aged; Calcium Channel Blockers; Cardiomyopathies; Child; Doxorubicin; Female; Hea | 1983 |
[Late cardiac sequelae in children following long-term tocolysis with fenoterol and verapamil].
Topics: Arrhythmias, Cardiac; Cardiomyopathies; Child; Electrocardiography; Ethanolamines; Female; Fenoterol | 1982 |
[Myocardial disease caused by adriamycin. Experimental animal models and possible pharmacologic prevention].
Topics: Animals; Cardiomyopathies; Carnitine; Disease Models, Animal; Doxorubicin; Mice; Rabbits; Rats; Razo | 1982 |
Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis.
Topics: Animals; Cardiomyopathies; Coronary Circulation; Cricetinae; Mesocricetus; Microcirculation; Muscle, | 1982 |
Myocardial protection from ischemic arrest: potassium and verapamil cardioplegia.
Topics: Animals; Cardiomyopathies; Cardiopulmonary Bypass; Dogs; Heart Arrest, Induced; Mitochondria, Heart; | 1981 |
Adriamycin experimental cardiomyopathy in Swiss mice. Different effects of two calcium antagonistic drugs on ADM - induced cardiomyopathy.
Topics: Animals; Body Weight; Calcium Channel Blockers; Cardiomyopathies; Doxorubicin; Drug Interactions; Mi | 1981 |
[Does the calcium antagonist verapamil protect from myocardial damage during tocolysis with beta-sympathicomimetics? (author's transl)].
Topics: Animals; Cardiomyopathies; Dogs; Female; Fenoterol; Heart Rate; Myocardial Contraction; Obstetric La | 1980 |
Use of explanted human hearts as a model for the study of cardiac pathophysiologic conditions.
Topics: Adult; Blood Pressure; Calcium; Cardiomyopathies; Epinephrine; Female; Heart; Heart Failure; Humans; | 1995 |
Positive inotropic effect of acetylcysteine in cardiomyopathic Syrian hamsters.
Topics: Acetylcysteine; Analysis of Variance; Animals; Cardiomyopathies; Cricetinae; Cysteine; Cystine; Male | 1993 |
Cardiotoxicity of doxorubicin: effects of drugs inhibiting the release of vasoactive substances.
Topics: Animals; Aspirin; Body Weight; Calcium; Cardiomyopathies; Catecholamines; Cromolyn Sodium; Doxorubic | 1994 |
Cardiomyopathic hamster hearts: long-term effects of drugs on catecholamine contents and binding characteristics of alpha 1- and beta 1-adrenergic receptors.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Cardiomyopathies; Catecholamines | 1993 |
Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis.
Topics: Amyloidosis; Cardiac Output, Low; Cardiomyopathies; Heart Failure; Humans; Male; Middle Aged; Stroke | 1993 |
Verapamil induced reduction of the myocardial beta-adrenoceptor density in BIO 14.6 cardiomyopathic Syrian hamsters.
Topics: Animals; Binding, Competitive; Calcium Channels; Cardiomyopathies; Cricetinae; Disease Models, Anima | 1993 |
Effect of trimetazidine and verapamil on the cardiomyopathic hamster myosin phenotype.
Topics: Animals; Calcium Channel Blockers; Calcium-Transporting ATPases; Cardiomyopathies; Cricetinae; Elect | 1998 |
[Verapamil sensitive ventricular tachycardia with myocardial failure in a 2-year-old child].
Topics: Adult; Anti-Arrhythmia Agents; Cardiomyopathies; Child, Preschool; Echocardiography; Electrocardiogr | 1999 |
Application of cardiac gated magnetic resonance imaging in murine Chagas' disease.
Topics: Analysis of Variance; Animals; Calcium Channel Blockers; Cardiomyopathies; Chagas Cardiomyopathy; En | 1999 |
Cardioprotective efficacy of verapamil and mibefradil in young UM-X7.1 cardiomyopathic hamsters.
Topics: Animals; Biomarkers; Calcinosis; Calcium Channel Blockers; Cardiomyopathies; Cardiovascular Agents; | 1999 |
Cardiomyopathic changes in streptozotocin-induced diabetes.
Topics: Adenosine Triphosphatases; Animals; Body Weight; Calcium Channel Blockers; Cardiomyopathies; Cardiot | 1999 |
Sarcoglycan, the heart, and skeletal muscles: new treatment, old drug?
Topics: Animals; Cardiomyopathies; Cytoskeletal Proteins; Disease Models, Animal; Dystroglycans; Dystrophin; | 2001 |
Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex.
Topics: Age Factors; Animals; Cardiomyopathies; Carrier Proteins; Coronary Circulation; Cytoskeletal Protein | 2001 |
Attenuation of verapamil-induced myocardial toxicity in an ex-vivo rat model using a verapamil-specific ovine immunoglobin.
Topics: Animals; Calcium Channel Blockers; Cardiomyopathies; Drug Therapy, Combination; Immunoglobulin G; Ma | 2001 |
Effect of volatile anesthetics on the force-frequency relation in human ventricular myocardium: the role of the sarcoplasmic reticulum calcium-release channel.
Topics: Anesthetics, Inhalation; Calcium Channel Blockers; Calcium Channels; Cardiomyopathies; Culture Techn | 2001 |
Role of cardiovascular and ionic changes in pathogenesis and prevention of isoprenaline-induced cardiac necrosis.
Topics: Animals; Blood Pressure; Carbon Dioxide; Cardiomyopathies; Heart Rate; Hydrogen-Ion Concentration; I | 1975 |
[Proceedings: Prevention of myocardial degeneration in a disease model of hereditary cardiomyopathy].
Topics: Animals; Calcium; Cardiomegaly; Cardiomyopathies; Cricetinae; Disease Models, Animal; Heart; Myocard | 1975 |
Co-existing aortic stenosis and secondary hypertrophic cardiomyopathy manifested by an hourglass left ventricle. Successful treatment with verapamil.
Topics: Aortic Valve Stenosis; Cardiomegaly; Cardiomyopathies; Heart Ventricles; Humans; Male; Middle Aged; | 1979 |
The effect of a calcium antagonist (D600) on isoprenaline-induced myocardial necrosis in the rat.
Topics: Animals; Calcium; Cardiomyopathies; Gallopamil; Isoproterenol; Male; Myocardium; Necrosis; Rats; Ver | 1979 |
[Does myocardial damage arise as a result of administration of tocolytic drugs? (author's transl)].
Topics: Abortion, Threatened; Adolescent; Adult; Cardiomyopathies; Creatine Kinase; Female; Humans; Isoenzym | 1979 |
[Chronic toxicities of adriamycin (ADR) and their possible prevention by coenzyme Q10 and verapamil in rabbits--especially ADR induced cardiomyopathy (author's transl)].
Topics: Animals; Cardiomyopathies; Doxorubicin; Myocardium; Rabbits; Ubiquinone; Verapamil | 1979 |
[Does myocardial damage arise as a result of administration of tocolytic drugs? (author's transl)].
Topics: Adolescent; Adult; Cardiomyopathies; Creatine Kinase; Female; Humans; Isoenzymes; Obstetric Labor, P | 1979 |
Electrophysiological study of Syrian hamster hereditary cardiomyopathy.
Topics: Action Potentials; Animals; Cardiomyopathies; Cricetinae; Gallopamil; In Vitro Techniques; Membrane | 1978 |
[Treatment of hypertrophic obstructive cardiomyopathy using verapamil].
Topics: Adult; Cardiomyopathies; Drug Evaluation; Female; Humans; Male; Middle Aged; Verapamil | 1976 |
Prevention of hereditary cardiomyopathy in the hamster by verapamil and other agents.
Topics: Animals; Body Weight; Calcium; Cardiomyopathies; Cell Membrane; Cinnarizine; Creatine Kinase; Cricet | 1975 |
Restriction of isoproterenol-induced myocardial Ca uptake and necrotization in rats by a new Ca-antagonistic compound (ethyl-4-(3,4,5-trimethoxycinnamoyl) piperazinyl acetate (Vascordil)).
Topics: Animals; Biological Transport; Calcium; Cardiomyopathies; Cinnamates; Dose-Response Relationship, Dr | 1975 |
Disturbed myocardial calcium metabolism: a possible pathogenetic factor in the hereditary cardiomyopathy of the Syrian hamster.
Topics: Age Factors; Animals; Calcium; Cardiomyopathies; Cricetinae; Female; Heart; Isoproterenol; Male; Ver | 1975 |
Prevention of myocardial generation in hamsters with hereditary cardiomyopathy.
Topics: Alkaline Phosphatase; Animals; Cardiomyopathies; Cricetinae; Dibenzylchlorethamine; Female; Male; Mu | 1975 |
Key role of Ca in the production of noncoronarogenic myocardial necroses.
Topics: Adenosine Triphosphate; Animals; Calcium; Cardiomyopathies; Heart; Humans; Isoproterenol; Muscles; N | 1975 |
Cocaine abuse: an expanding healthcare problem for the 1990s.
Topics: Adult; Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Cardiomyopathies; C | 1992 |
Alterations in Ca(2+)-channels during the development of diabetic cardiomyopathy.
Topics: Animals; Blood Glucose; Brain; Calcium; Calcium Channels; Calcium-Transporting ATPases; Cardiomyopat | 1992 |
Inotropic effects of calcium antagonists in the cardiomyopathic Syrian hamster.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Effects of verapamil on the acute toxicity of doxorubicin in vivo.
Topics: Animals; Cardiomyopathies; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Heart; | 1992 |
Inotropic and calcium kinetic effects of calcium channel agonist and antagonist in isolated cardiac myocytes from cardiomyopathic hamsters.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Altered inotropic responses in diabetic cardiomyopathy and hypertensive-diabetic cardiomyopathy.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Hypertensive-diabetic cardiomyopathy in rats.
Topics: Analysis of Variance; Animals; Biomechanical Phenomena; Cardiomyopathies; Contractile Proteins; Diab | 1990 |
[3H]-nitrendipine binding in normal and cardiomyopathic hamster hearts: modulation by temperature, verapamil and diltiazem.
Topics: Allosteric Regulation; Animals; Binding Sites; Calcium Channels; Cardiomyopathies; Cricetinae; Dihyd | 1990 |
Chronic calcium channel blockade prevents the progression of myocardial contractile and electrical dysfunction in the cardiomyopathic Syrian hamster.
Topics: Animals; Calcium Channel Blockers; Cardiomyopathies; Cricetinae; Heart; Heart Failure; Membrane Pote | 1990 |
Effects of verapamil on chronic doxorubicin-induced cardiotoxicity in dogs.
Topics: Animals; Cardiomyopathies; Dogs; Doxorubicin; Heart; Verapamil | 1990 |
[Ultrastructural changes in the myocardium in immune damage to the heart].
Topics: Animals; Calcium; Cardiomyopathies; Cytotoxicity, Immunologic; Dogs; Glycoproteins; Immune Sera; Imm | 1986 |
Inhomogenous capillary flow and its prevention by verapamil and hydralazine in the cardiomyopathic Syrian hamster.
Topics: Animals; Capillaries; Cardiomyopathies; Cricetinae; Female; Hydralazine; Male; Mesocricetus; Myocard | 1987 |
Influence of verapamil on some subcellular defects in diabetic cardiomyopathy.
Topics: Adenosine Triphosphatases; Animals; Biological Transport; Calcium; Calcium-Transporting ATPases; Car | 1989 |
Cardiomyopathy in phaeochromocytoma: a case report.
Topics: Adrenal Gland Neoplasms; Adult; Anesthesia, Inhalation; Cardiomyopathies; Humans; Male; Multiple End | 1989 |
Dual tracer autoradiographic study with thallium-201 and radioiodinated fatty acid in cardiomyopathic hamsters.
Topics: Animals; Autoradiography; Cardiomyopathies; Cricetinae; Endocardium; Fatty Acids; Heart Septum; Hear | 1989 |
Prevention of hereditary cardiomyopathy in the Syrian hamster with chronic verapamil therapy.
Topics: Adenosine Triphosphatases; Animals; Cardiomyopathies; Cricetinae; Mesocricetus; Myosins; Spasm; Vera | 1988 |
Verapamil sensitizes cardiomyopathic hamsters to the effects of stress.
Topics: Animals; Cardiomyopathies; Coronary Vasospasm; Cricetinae; Stress, Physiological; Verapamil | 1988 |
Beneficial effects of verapamil in diabetic cardiomyopathy.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Calcium; Cardiomyop | 1988 |
Comparison of verapamil and bepridil in the therapy of familiar cardiomyopathy of the Syrian hamster.
Topics: Animals; Bepridil; Calcium; Cardiomyopathies; Cricetinae; Muscles; Necrosis; Osmolar Concentration; | 1987 |
Verapamil in the prevention of adriamycin-induced cardiomyopathy.
Topics: Cardiomyopathies; Doxorubicin; Echocardiography; Humans; Myocardial Contraction; Verapamil | 1986 |
Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure.
Topics: Adolescent; Adult; Calcium; Cardiomyopathies; Diastole; Female; Heart; Hemodynamics; Humans; Intrace | 1987 |
Calcium reverses global and regional myocardial dysfunction caused by the combination of verapamil and halothane.
Topics: Animals; Calcium Chloride; Cardiomyopathies; Coronary Circulation; Halothane; Heart; Hemodynamics; S | 1987 |
Effects of L-carnitine and verapamil on myocardial carnitine concentration and histopathology of Syrian hamster BIO 14.6.
Topics: Animals; Calcinosis; Cardiomyopathies; Carnitine; Cricetinae; Fibrosis; Mesocricetus; Myocardium; Ne | 1986 |
Evaluation of the hereditary Syrian hamster cardiomyopathy by 31P nuclear magnetic resonance spectroscopy: improvement after acute verapamil therapy.
Topics: Adenosine Triphosphate; Animals; Cardiomyopathies; Cricetinae; Glucose; Hemodynamics; Hydrogen-Ion C | 1986 |
The usefulness of electrophysiological-pharmacologic studies in the long-term therapy of paroxysmal tachycardias.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiomyopathies; Chromatogra | 1985 |
Systemic influence of intravesical chemotherapy with verapamil.
Topics: Animals; Calcium Channel Blockers; Cardiomyopathies; Doxorubicin; Drug Evaluation, Preclinical; Fema | 1985 |
Systemic hypertension induces disparate localized left ventricular action potential lengthening and altered sensitivity to verapamil in left ventricular myocardium.
Topics: Action Potentials; Animals; Cardiomyopathies; Cats; Electric Stimulation; Female; Heart Conduction S | 1986 |
Morphological findings in apparently idiopathic ventricular tachycardia. An echocardiographic haemodynamic and histologic study.
Topics: Adult; Aged; Amiodarone; Biopsy; Bundle-Branch Block; Cardiomyopathies; Drug Therapy, Combination; E | 1985 |
Effects of verapamil and taurine administration on heart taurine and calcium in BIO 14.6 cardiomyopathic hamsters.
Topics: Animals; Binding Sites; Calcium; Cardiomyopathies; Cricetinae; Female; Heart; Male; Mesocricetus; My | 1985 |
Effect of verapamil on uremic myocardial disease in the rat.
Topics: Animals; Blood Urea Nitrogen; Cardiomyopathies; Creatinine; Male; Microscopy, Electron; Myocardium; | 1985 |
Myocardial fiber necrosis due to intracellular Ca overload-a new principle in cardiac pathophysiology.
Topics: Ammonium Chloride; Animals; Biological Transport; Calcitonin; Calcium; Cardiomyopathies; Dihydrotach | 1974 |
Ca overload as the determinant factor in the production of catecholamine-induced myocardial lesions.
Topics: Adenosine Triphosphate; Animals; Calcium; Cardiomyopathies; Dihydrotachysterol; Heart; Hydrocortison | 1973 |